The role of TRAP exposure in the development and persistence of asthma and low lung function

G. Bowatte (Reservoir, Australia)

Source: International Congress 2017 – Asthma from childhood to adulthood and ACOS
Session: Asthma from childhood to adulthood and ACOS
Session type: Poster Discussion
Number: 3511
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
G. Bowatte (Reservoir, Australia). The role of TRAP exposure in the development and persistence of asthma and low lung function. 3511

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
High airway responsiveness as a risk factor for lung function decline
Source: Annual Congress 2010 - Airway responsiveness, chronic cough and bronchiectasis: a modern approach
Year: 2010

Crucial role for lung iron level and regulation in the pathogenesis and severity of asthma
Source: Eur Respir J, 55 (4) 1901340; 10.1183/13993003.01340-2019
Year: 2020



The role of lung function testing and eNO in monitoring asthma
Source: Annual Congress 2013 –Primary Care Programme "Asthma management in clinical practice"
Year: 2013


SNPs which influence the transcriptional response to acute smoke exposure are associated with long term lung function decline in smokers
Source: International Congress 2018 – Functional genomics and COPD: new challenges
Year: 2018

Monitoring asthma in childhood: lung function, bronchial responsiveness and inflammation
Source: Eur Respir Rev 2015; 24: 204-215
Year: 2015



Assessing small airway function for early detection of lung function impairment
Source: Eur Respir J, 56 (1) 2001946; 10.1183/13993003.01946-2020
Year: 2020



Do bacteria have a role in asthma development?
Source: Eur Respir J 2010; 36: 469-471
Year: 2010


Combined impact of smoking and early life exposures on adult lung function
Source: International Congress 2017 – Factors associated with lung function development
Year: 2017

Does maternal smoking play a role as an inducer, rather than trigger, of asthma and respiratory symptoms?
Source: Annual Congress 2011 - Paediatric epidemiology: predicting outcomes of wheeze, antenatal growth, early life exposures and outcome of premature birth
Year: 2011


The role of infections as a trigger of COPD exacerbations and decline of lung function
Source: Annual Congress 2011 - Epidemiology of COPD exacerbations
Year: 2011


Study on levels of high sensitivity C reactive protein in asthmatic patients during exacerbation and remission and its correlation with pulmonary function
Source: Annual Congress 2007 - Mechanisms of airway inflammation
Year: 2007



The role of genes coding Glutation-S-Transferase M1 and T1 as risk factors for the development of bronchial asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 502s
Year: 2001

B cells in different stages of development increase in the lung in a murine model of airway allergic inflammation
Source: Annual Congress 2009 - Animal models of airways inflammation
Year: 2009


Effect of maternal nicotine exposure during different phases of lung development on neonatal lung development: long term consequences
Source: Eur Respir J 2005; 26: Suppl. 49, 366s
Year: 2005

The role of inflammatory biomarkers like precursors of COPD stability during long-term follow-up
Source: International Congress 2019 – Research and innovation in airway diseases
Year: 2019


Determinants of excessive lung function decline in subjects exposed to occupational agents
Source: Annual Congress 2012 - Respiratory diseases at at work: epidemiology, inflammation and challenge studies
Year: 2012

Immunoproteasome function as a potential biomarker for asthma severity and response to therapy
Source: Virtual Congress 2021 – Emerging new mechanisms of chronic lung disease
Year: 2021


Small airways function: evaluation in a population of adult patients with severe asthma and potential use as a response biomarker for anti-IL5 therapy
Source: Virtual Congress 2020 – Monoclonal antibodies; randomised controlled trials and real-world studies in asthma
Year: 2020